In short, during NAFLD’s evolution to HCC, we observed a marked reduction in translational capability with the notable exception of eIF6 levels, which increase in order to sustain lipid metabolism at the translational level [12]. The gene discussed is EIF6; the disease is metabolic dysfunction-associated steatotic liver disease.